102
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Distribution of yeast species associated with oral lesions in HIV-infected patients in Southwest Uganda

, , , , &
Pages 276-280 | Received 11 Mar 2011, Accepted 10 Jul 2011, Published online: 12 Sep 2011

References

  • Calderone RA. Introduction and historical perspectives. Calderone RA Candida and Candidiasis, 1st. Washington, DC: ASM Press, 2002: 3–13.
  • Greenspan JS, Greenspan D. The epidemiology of the oral lesions of HIV infection in the developed world. Oral Dis 2002; 8 (Suppl. 2): 34–39.
  • Coleman DC, Bennett DE, Sullivan DJ, . Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Crit Rev Microbiol 1993; 19: 61–82.
  • Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 2000; 29: 336–341.
  • Hood S, Bonington A, Evans J, Denning D. Reduction in oropharyngeal candidiasis following introduction of protease inhibitors. AIDS 1998; 12: 447–448.
  • Tirwomwe JF, Rwenyonyi CM, Muwazi LM, Besigye B, Mboli F. Oral manifestations of HIV/AIDS in clients attending TASO clinics in Uganda. Clin Oral Investig 2007; 11: 289–292.
  • Hamza OJ, Matee MI, Moshi MJ, . Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiology 2008; 8: 135.
  • Thompson GR 3rd, Patel PK, Kirkpatrick WR, . Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 2010; 109: 488–495.
  • Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141: 1507–1521.
  • Agwu E, Ihongbe JC, Tirwomwe JF, . Appraisal of oral lesions status of HIV/AIDS patients in South Western Uganda. Braz J Oral Sci 2008; 7: 1591–1595.
  • World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. Geneva: The World Health Organization; 2006.
  • EC-Clearinghouse. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22: 289–291.
  • Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994; 32: 1923–1929.
  • Al-Mosaid A, Sullivan DJ, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Pal's Agar. J Clin Microbiol 2003; 41: 4787–4789.
  • Sahand IH, Maza JL, Eraso E, . Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity. J Med Microbiol 2009; 58: 1437–1442.
  • Donnelly SA, Sullivan DJ, Shanley DB, Coleman DC. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 1999; 145: 1871–1882.
  • McManus BA, McGovern E, Moran GP, . Microbiological screening of Irish autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients reveals persistence of Candida albicans strains, gradual reduction in susceptibility to azoles and incidences of clinical signs of oral candidiasis without culture evidence J Clin Microbiol 2011; 49: 1879–1889.
  • Enwuru CA, Ogunledun A, Idika N, . Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Afr Health Sci 2008; 8: 142–148.
  • Melo NR, Taguchi H, Culhari VP, . Oral candidiasis of HIV-infected children undergoing sequential HIV therapies. Med Mycol 2009; 47: 149–156.
  • Hood SV, Moore CB, Denning DW. Isolation of Candida norvegensis from clinical specimens: four case reports. Clin Infect Dis 1996; 23: 1185–1187.
  • Pfaller MA, Diekema DJ, Gibbs DL, . Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 2010; 48: 1366–1377.
  • Sullivan DJ, Moran GP, Coleman DC. Candida dubliniensis: ten years on. FEMS Microbiol Lett 2005; 253: 9–17.
  • Kibbler CC, Ainscough S, Rosemary A. Barnes, et al. Management and outcome of blood stream infections due to Candida species in England and Wales. J Hosp Infect 2003; 54: 18–24.
  • Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol 1998; 36: 329–334.
  • Al Mosaid A, Sullivan D, Salkin IF, Shanley D, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol 2001; 39: 323–327.
  • Blignaut E. Oral candidiasis and oral yeast carriage among institutionalised South African paediatric HIV/AIDS patients. Mycopathologia 2007; 163: 67–73.
  • Blignaut E, Pujol C, Joly S, Soll DR. Racial distribution of Candida dubliniensis colonization among South Africans. J Clin Microbiol 2003; 41: 1838–1842.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.